Neuromuscular Blocking Agents for Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials

2020 
Backgrounds The aim of this study is investigating the benefits and harms of neuromuscular blocking agents (NMBAs) in patients with acute respiratory distress syndrome (ARDS).
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    40
    References
    7
    Citations
    NaN
    KQI
    []